The annual meeting of the European Society of Cardiology (ESC), this year organised in Munich, had again a lot to offer to the interventional cardiologist. Important new data were presented on important topics such as: real life safety of the first generation drug eluting stents, new stent technology and the timing of adjunctive antithrombotic therapy in conjunction with primary PCI. Long awaited data was also released on large scale randomised trials comparing contemporary percutaneous (PCI) and surgical (CABG) revascularisation.
The main session on DES safety “Two years after Barcelona” stressed the importance of large scale registries because these reflect ...
1. Department of Internal Medicine, Heilig Hart Hospital, Roeselare, Belgium; 2. Cardiology Clinic, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; 3. Interventional Cardio- Angiology Unit, Villa Maria Cecilia Hospital, Cotignola, Italy
Sign in to read and download the full article
Forgot your password?No account yet? Sign up for free!
Create my pcr account Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
Read next article
Four-year safety and efficacy of the unrestricted use of sirolimus- and paclitaxel-eluting stents in coronary artery bypass grafts